1785CHAPTER 234 Schistosomiasis and Other Trematode Infections
in (trekking, swimming, whitewater rafting)? What have you been
eating (local dishes while traveling; raw, poorly cooked, or pickled
freshwater fish or crustaceans)? Definitive diagnosis is based on
detection of parasite eggs in stool, urine, sputum, and sometimes
tissue samples or on serologic tests. The presence of eosinophilia
and a history of travel to endemic areas should raise suspicion of
trematode infection. The U.S. Centers for Disease Control and
Prevention (CDC) can provide guidance with respect to diagnosis
and treatment.
SCHISTOSOMIASIS
Human schistosomiasis is caused by six species of the parasitic genus
Schistosoma: S. mansoni, S. japonicum, S. mekongi, S. intercalatum, and
the recently described S. guineensis cause intestinal disease, and S. haematobium causes urogenital disease (Table 234-1). The infection may
cause considerable intestinal, hepatic, and genitourinary morbidity.
Avian schistosomes may penetrate human skin, but they die in subcutaneous tissue, producing only cutaneous manifestations.
■ ETIOLOGY
Schistosoma infection is contracted through contact with freshwater
bodies harboring infected intermediate-host snails. Cercariae, the
infective larval stage released from the snail, penetrate intact human
skin within a few minutes after attaching to the skin. After penetration,
the cercariae transform to schistosomula, which then enter a small
vein or lymphatic vessel, circulate in the bloodstream through the
lung capillaries, and are pumped via the heart to all parts of the body
to reach the portal vein. There, the worms mature into adult males or
females, pair, and migrate to their final location in the mesenteric or
pelvic venous plexus.
The interval from cercarial penetration to sexual maturation and
egg production, termed the prepatent period, lasts 5–7 weeks (up to 12
weeks for S. haematobium). The female worm then begins to produce
eggs, which are excreted via feces or, for S. haematobium, urine. Approximately 50% of eggs are retained in tissue, where they are responsible for
organ-specific morbidity (see “Pathogenesis,” below). When excreted
eggs reach water, they hatch and release a free-swimming larval stage
(miracidium), which, after penetrating a host snail, undergoes several
rounds of asexual multiplication. After ~4–6 weeks, infective cercariae
are shed from the infected snails into the water. One snail, infected by
one miracidium, can shed thousands of cercariae per day for several
months; thus, the transmission potential of schistosomes is enormous.
The schistosome egg (Fig. 234-1) is the only stage of the parasites’
life cycle that can be detected in humans, either in excreta or in tissue
biopsies. The eggs are large and can easily be distinguished morphologically from other helminth eggs. S. haematobium eggs are ~140 mm long,
with a terminal spine; S. mansoni eggs are ~150 mm long, with a lateral
FIGURE 234-1 Schistosoma haematobium eggs.
spine; and S. japonicum eggs are smaller, rounder, and ~90 mm long,
with a small lateral spine or knob.
Adult schistosomes are ~1–2 cm long. The male worm is flat, and
the body forms a groove or gynecophoric canal in which the mature
adult female is held like a sausage in a hotdog roll. Females are longer,
thinner, and rounded. The females produce hundreds (African species)
to thousands (Asian species) of eggs per day. Each ovum contains a
ciliated miracidium larva, which secretes proteolytic enzymes that help
the eggs to migrate into the lumen of the bladder (S. haematobium) or
the intestine (other species). The lifespan of an adult schistosome averages 3–5 years but can be as long as 30 years. Schistosome worms feed
on red blood cells; the debris is regurgitated in the host’s blood, where
it can be detected as circulating antigens (see “Diagnosis,” below).
Adult schistosomes persist in the bloodstream for years and have
evolved strategies of evading attack using immune effector mechanisms. This immune evasion is a result of several processes, such as
binding of host proteins to the schistosome surface, which renders the
parasite invisible to the host immune system.
The genome of schistosomes is relatively large (~300 Mb).
Whole-genome sequences are available for S. mansoni, S. japonicum, and S. haematobium.
■ EPIDEMIOLOGY
Because of the complex life cycle of schistosomes, with snails as an
intermediate host and humans as the final host, transmission is dependent on freshwater habitats that are suitable for the snails, are areas of
human activity, and have climatic conditions favoring the survival of
the snails and the development of the parasites inside the snail host.
These requirements are reflected in the global distribution of schistosomiasis as well as in its microgeographic distribution within an endemic
area. For S. mansoni, S. haematobium, S. intercalatum and S. guineensis, humans are the most important definitive host. S. japonicum and
S. mekongi are zoonotic parasites, with a wide range of definitive hosts
such as pigs, water buffaloes, and various rodents.
It is estimated that 229 million people are infected globally and
at least 229 million people required preventive treatment in 2018.
Schistosomiasis transmission has been reported from 78 countries,
of which 52 endemic countries have moderate to high transmission
(Fig. 234-2). More than 70% of infected people live in sub-Saharan
Africa. Schistosomiasis is the most important of the neglected tropical
diseases and is second only to malaria in public health impact. It is
a poverty-related disease, and infection is prevalent in areas where
adequate water supplies and sanitary facilities are lacking. In these
areas, people come into contact with infested water through a variety
of activities, including bathing, washing clothes, and collecting water
for drinking or cooking. In some areas, adults have a high occupational
risk of exposure; fishermen, canal cleaners, and workers in rice fields
fall into this category. Among children, playing in water and swimming
pose a risk. Large-scale irrigation and hydroelectric power operations
can create suitable habitats for host snails and thus increase the risk of
schistosomiasis transmission.
In general, children living in endemic areas initially acquire infection at ~3–4 years of age—i.e., when they are old enough to walk
and come into contact with infested water. However, infection does
occur in much younger children. As children grow older, the prevalence and intensity of infection increase, peaking around puberty. A
characteristic feature of schistosomiasis infection in human populations is a convex age–prevalence curve, with low prevalence in very
young children, higher prevalence in older children with a peak at
10–15 years of age, and declining prevalence in adults. The same
pattern is observed between age and intensity of infection and is
attributable to various factors. Generally, children have more frequent,
prolonged, and extensive water contact than adults through activities
like playing and swimming. Furthermore, several studies have indicated that acquired immunity to schistosomiasis develops slowly over
several years, so that adults are reinfected to a much lesser extent than
children. These factors, combined with progressive spontaneous death
of adult worms from infections acquired during childhood, lead to
lower levels of infection in the adult population.
1786 PART 5 Infectious Diseases
■ PATHOGENESIS
Cercarial invasion may be associated with dermatitis arising from
dermal and subdermal inflammatory reactions in response to dying
cercariae that trigger innate immune responses. However, most manifestations of schistosomiasis—in the acute, established, and chronic
phases of infection—are due to immunologic reactions to eggs retained
in host tissues.
Around the time when oviposition commences, acute schistosomiasis (Katayama fever) may occur (see “Clinical Features,” below).
Antigen excess from eggs results in the formation of soluble immune
complexes, which may be deposited in several tissues and initiate a
serum sickness–like illness. All evidence suggests that schistosome
eggs, and not adult worms, induce the organ-specific morbidity
caused by schistosome infections. Approximately half of the eggs are
not excreted via feces or urine but are trapped in intestinal or hepatic
tissue (S. mansoni, S. japonicum, and S. mekongi) or in the bladder
and urogenital system (S. haematobium). The eggs induce a granulomatous host immune response composed primarily of lymphocytes,
eosinophils, and alternatively activated macrophages. The lymphocytes
produce various TH2 cytokines such as interleukins 4, 5, and 13. Later,
in the chronic phase of infection, regulatory cytokines are responsible for immunomodulation or downregulation of host responses to
schistosome eggs and play an important role in reducing the size of
granulomas.
When S. mansoni or S. japonicum eggs are swept into the small
portal branches of the liver via the portal vein, they lodge in the
presinusoidal periportal tissues. The formation of granulomas around
the eggs can cause significant enlargement of the spleen and liver.
High-intensity infections in children are often accompanied by hepatosplenomegaly that generally decreases over time, partly because the
number of eggs being deposited in the tissue gradually declines after
the early teenage years as partial immunity to new infections develops
and partly because of immunologic downregulation of the granulomatous response. However, in some infected individuals, egg-induced
granulomatous responses lead to severe periportal fibrosis (Symmers
clay pipestem fibrosis), with deposition of collagen around the portal
vein, occlusion of the smaller portal branches, and severe, often irreversible, pathology. Occlusion of the portal branches may result in
marked portal hypertension.
The signs and symptoms of S. haematobium infection relate to the
worms’ predilection for the veins of the urogenital plexus and result
from deposition of eggs in the bladder, ureters, and genital organs.
During established active infection, clusters of living eggs in the
urogenital tissues can be found surrounded by intense inflammatory
reactions and intense tissue eosinophilia. Movement of egg clusters
into the lumen of the bladder is often followed by sloughing off of the
epithelial surface, ulceration, and bleeding. Intense egg-induced tissue
inflammation can result in bladder wall thickening and development
of masses and pseudopolyps. Inflammation and granuloma formation
around the ureteral ostia can lead to hydronephrosis.
Generally, late chronic-stage infections are characterized by accumulation of dead calcified eggs in tissue. Characteristic cervical lesions
are found in S. haematobium infections, including active-stage lesions
with intense tissue inflammation around live eggs and chronic-stage
sandy patches with clusters of calcified eggs.
■ CLINICAL FEATURES
In general, disease manifestations of schistosomiasis occur in three
stages—acute, active, and chronic—according to the duration and
intensity of infection.
Cercarial Dermatitis (“Swimmer’s Itch”) Cercarial penetration of the skin may result in a maculopapular rash called cercarial
dermatitis or “swimmer’s itch.” Cercarial dermatitis can develop in
people who have not previously been exposed to schistosomiasis (e.g.,
travelers), whereas it is rare among people living in endemic areas.
A particularly severe form of cercarial dermatitis is commonly seen
after exposure to cercariae from avian schistosomes. These cercariae
cannot complete their development in humans and die in the skin,
causing an inflammatory allergic reaction. This form of cercarial dermatitis can occur in people who have been in contact with water from
lakes (e.g., in Europe or the United States) where various species of
water birds, such as ducks, geese, and swans, are found. The rash may
last for 1–2 weeks. This condition normally requires no treatment, but
systemic antihistamines, topical antihistamines, or glucocorticoids can
be used to reduce symptoms.
Acute Schistosomiasis (Katayama Fever) Symptomatic acute
schistosomiasis, also known as Katayama fever or Katayama syndrome,
is usually seen in travelers who have contracted the infection for the
first time. The onset occurs between 2 weeks and 3 months after exposure to the parasite. The symptoms may appear suddenly and include
fever, myalgia, general malaise and fatigue, headache, nonproductive
A B
FIGURE 234-2 Global distribution of human schistosomiasis. A. Schistosoma mansoni infection (dark blue) is endemic in Africa, the Middle East, South America, and a few
Caribbean countries. S. intercalatum infection (green) is endemic in sporadic foci in West and Central Africa. B. Schistosoma haematobium infection (purple) is endemic in
Africa and the Middle East. The major endemic countries for S. japonicum infection (green) are China, the Philippines, and Indonesia. Schistosoma mekongi infection (red)
is endemic in sporadic foci in Southeast Asia. (Reprinted from CH King, AAF Mahmoud: Schistosomiasis and other trematode infections, in DL Kasper et al [eds], Harrison’s
Principles of Internal Medicine, 19th ed. New York, McGraw-Hill Education, 2015, pp 1423–1429.)
1787CHAPTER 234 Schistosomiasis and Other Trematode Infections
cough, and intestinal symptoms such as abdominal tenderness or
pain. Various combinations of these symptoms are often accompanied
by eosinophilia and transient pulmonary infiltrates. Many patients
recover spontaneously from acute schistosomiasis after 2–10 weeks,
but the illness follows a more severe clinical course in some individuals,
with weight loss, dyspnea, diarrhea, and hepatomegaly. Severe cerebral
or spinal cord manifestations may occur, and even light infections may
cause severe illness. The syndrome can, in rare cases, be fatal.
Differential diagnosis includes many other febrile infectious diseases with acute onset, including malaria, salmonellosis, and acute hepatitis. Fever and eosinophilia occur in trichinosis, tropical eosinophilia,
invasive ankylostomiasis, strongyloidiasis, visceral larva migrans, and
infections with Opisthorchis and Clonorchis species. Katayama fever is
rare in people chronically exposed to infection in areas endemic for
S. mansoni or S. haematobium.
Intestinal Schistosomiasis (S. mansoni, S. japonicum) In intestinal schistosomiasis, adult worms are located in the mesenteric veins,
and disease manifestations are associated with parasite eggs passing
through or becoming trapped in intestinal tissue. This event induces
mucosal granulomatous inflammation with microulcerations, superficial bleeding, and sometimes pseudopolyposis. The symptoms tend
to be more pronounced with a high intensity of infection and include
intermittent abdominal pain, loss of appetite, and sometimes bloody
diarrhea. The clinical manifestations of S. intercalatum, S. guineensis,
and S. mekongi infection are generally milder.
Hepatosplenic Schistosomiasis Hepatosplenic schistosomiasis
is caused by schistosome eggs trapped in liver tissue and occurs in
S. mansoni and S. japonicum infections. There are two distinct clinical
entities: early inflammatory hepatosplenomegaly and late hepatosplenic disease with periportal fibrosis.
Early inflammatory hepatosplenic schistosomiasis is the main
entity seen in children and adolescents. The liver is enlarged, especially the left lobe, and is smooth and firm. The spleen is enlarged,
often extending below the umbilicus, and is firm or hard. Generally,
ultrasonography shows no hepatic fibrosis. This form of hepatosplenic
schistosomiasis may be found in up to 80% of infected children. Its
severity is closely associated with the intensity of infection and may
also be associated with concomitant chronic exposure to malaria.
Late hepatosplenic schistosomiasis with periportal or Symmers fibrosis may develop in young and middle-aged adults with long-standing,
high-level exposure to infection. Patients with periportal fibrosis may
excrete very few or no eggs in feces. During the early stage, the liver
is enlarged, especially the left lobe; it is smooth and firm or hard. The
spleen is enlarged, often massively, and is firm or hard. The patient
may report a left hypochondrial mass with discomfort and anorexia.
Ultrasonography reveals typical periportal fibrosis and dilation of the
portal vein. Other complications include delayed growth and puberty,
especially in S. japonicum infections, and severe anemia. Severe hepatosplenic schistosomiasis may lead to portal hypertension, but hepatic
function usually remains normal, even in cases with marked periportal
fibrosis and portal hypertension.
Ascites, attributable both to portal hypertension and to hypoalbuminemia, may be seen, especially in S. japonicum infection. Patients
with severe hepatosplenic disease and portal hypertension may develop
esophageal varices detectable by endoscopy or ultrasound. These
patients may experience repeated bouts of hematemesis, melena, or
both. Hematemesis is the most severe complication of hepatosplenic
schistosomiasis, and death may result from massive loss of blood.
Urogenital Schistosomiasis (S. haematobium) The signs and
symptoms of S. haematobium infection relate to the worms’ predilection for the veins of the urogenital tract. Two stages of infection are
recognized. An active stage occurring mainly in children, adolescents,
and younger adults is characterized by egg excretion in the urine, with
proteinuria and macroscopic or microscopic hematuria and deposition
of eggs in the urinary tract. A chronic stage in older individuals is
characterized by sparse or no urinary egg excretion despite urogenital
tract pathology.
A characteristic sign in the active stage is painless, terminal hematuria. Dysuria and suprapubic discomfort or pain are associated with
active urogenital schistosomiasis and may persist throughout the
course of active infection. Eggs deposited in the bladder mucosa may
give rise to an intense inflammatory response of the bladder wall,
which may cause ureteric obstruction and lead to hydroureter and
hydronephrosis. These early inflammatory lesions, including obstructive uropathy, can be visualized by ultrasonography.
As the infection progresses, the inflammatory component decreases
and fibrosis becomes more prominent. The symptoms at this stage are
nocturia, urine retention, dribbling, and incontinence. Cystoscopy
reveals “sandy patches” composed of large numbers of calcified eggs
surrounded by fibrous tissue and an atrophic mucosal surface. The
ureters are less commonly involved, but ureteral fibrosis can cause
irreversible obstructive uropathy that can progress to uremia.
Egg deposition may cause granulomas and lesions in the genital
organs, most commonly in the cervix and vagina in women and the
seminal vessels in men. The results may include dyspareunia, abnormal
vaginal discharge, contact bleeding, and lower back pain in women and
perineal pain, painful ejaculation, and hematospermia in men. Genital
symptoms like bloody discharge and genital itch are associated with
S. haematobium infection in school-aged girls living in schistosomiasis-endemic areas. Symptoms such as hematospermia and perineal
discomfort have been described in travelers, and eggs have been demonstrated in seminal fluid. An association between female genital schistosomiasis and HIV infection has been demonstrated, but the impact of
genital schistosomiasis on HIV transmission needs further elucidation.
S. haematobium has been classified by the International Agency for
Research on Cancer (IARC) as definitely carcinogenic to humans (i.e.,
a group 1 carcinogen). Chronic S. haematobium infection is associated
with squamous cell carcinoma of the urinary bladder.
Other Manifestations Worms and eggs can sometimes be located
in ectopic sites, causing site-specific manifestations and symptoms.
Neuroschistosomiasis is one of the most severe clinical forms of schistosomiasis and is caused by the inflammatory response around eggs in
the cerebral or spinal venous plexus. S. mansoni and S. haematobium
worms can end up in the spinal venous plexus, where they may cause
transverse myelitis—an acute complication sometimes seen in travelers
returning home with schistosomiasis. S. japonicum is mainly associated
with granulomatous lesions in the brain, causing epileptic seizures,
encephalopathy with headache, visual impairment, motor deficit, and
ataxia. Pulmonary schistosomiasis is caused by portacaval shunting
of eggs into the lung capillaries, where they induce granulomas in the
perialveolar area. The consequences may be fibrosis, pulmonary hypertension, and cor pulmonale.
■ DIAGNOSIS
Anamnestic information on recent travels to endemic areas and exposure to freshwater bodies through recreational or other activities is
important in the diagnosis of schistosomiasis in travelers. Information
about exact geographic locations can facilitate identification of the
relevant species of Schistosoma. Eosinophilia is a common finding and
is often associated with helminthic infections such as schistosomiasis.
Detection of schistosome eggs in stool or urine is indicative of active
infection and is the standard diagnostic method. The diagnosis is often
based on the detection of eggs in a fixed small amount of excreta—e.g.,
50 mg of stool or filtration of 10 mL of urine. This method is widely
used among populations in endemic areas and allows quantitation of
the level of infection (eggs per gram of feces or per 10 mL of urine).
However, levels of egg excretion in people from nonendemic areas may
be very low, in which case a larger sample and concentration methods
(e.g., formol-ether concentration) may be needed.
Eggs can also be detected in rectal biopsies (both S. mansoni and
S. haematobium) and occasionally in Pap smears and semen samples
(S. haematobium). Polymerase chain reaction (PCR)–based detection
of parasite DNA in stool or urine is more sensitive than parasitologic
methods and is increasingly used. Schistosoma DNA can be detected
in cerebrospinal fluid samples for diagnosis of neuroschistosomiasis.
1788 PART 5 Infectious Diseases
Serology, with detection of specific antibodies to schistosomes, is
useful in travelers but less so in people from endemic areas where
transmission is ongoing. The serologic assays employed at the CDC
are a Falcon assay screening test/enzyme-linked immunosorbent assay
(FAST-ELISA) using S. mansoni adult microsomal antigen and a confirmatory species-specific immunoblot assay performed in light of the
patient’s travel history.
Schistosome proteoglycans—circulating anodic and cathodic antigens (CAAs and CCAs)—regurgitated into the bloodstream by the
feeding worms can be detected in serum and urine by ELISA or
monoclonal antibody–based lateral flow assays. The presence of CAA
or CCA is an indication of active infection, and levels of these antigens
correlate well with the intensity of infection. However, detection of
CAAs and CCAs is not currently suitable for diagnosis in travelers,
who are likely to have low levels of infection and very few worms, but
promising results have been obtained using an ultrasensitive lateral
flow assay. A commercially available point-of-care assay (Rapid Medical Diagnostics, Pretoria, South Africa) that detects CCA in urine is
now widely used for screening of infected communities in relation to
mass drug administration programs.
TREATMENT
Schistosomiasis
The drug of choice for treatment of schistosomiasis is praziquantel.
It is administered orally, is available as 600-mg tablets, and is effective against all schistosome species infecting humans. The drug is
safe and well tolerated. Standard regimens are shown in Table 234-2.
In patients who are not cured by initial treatment, the same dose
can be repeated at weekly intervals for 2 weeks. Since praziquantel
does not affect the young migrating stages of the schistosomes, it
may be necessary to repeat the dose 6–12 weeks later, especially if
eosinophilia or symptoms persist despite treatment.
As a general principle, all patients with acute schistosomiasis
should be treated with praziquantel. Glucocorticoids can be added
in Katayama fever to suppress the hypersensitivity reaction. However, treatment for acute schistosomiasis or Katayama fever must be
adjusted appropriately for each case, and in the most severe cases,
management in an acute-care setting is necessary.
Praziquantel is effective in cerebral S. japonicum infections,
resulting in rapid dissipation of cerebral edema and resolution of
cerebral masses. However, glucocorticoids and anticonvulsants are
sometimes needed in neuroschistosomiasis.
The effect of antischistosomal treatment on disease manifestations depends on the stage and severity of the lesions. Early hepatosplenomegaly, mild or moderate fibrosis, and urinary bladder
lesions seen during active infection resolve after chemotherapy.
However, for late-stage manifestations (e.g., severe fibrosis with
portal hypertension), praziquantel treatment is only one component of management, since the main complications are due to
obstructive pathology. Management of portal hypertension and
prevention of bleeding from esophageal varices should follow clinical guidelines for treatment of these conditions.
■ PREVENTION AND CONTROL
Schistosomiasis is contracted through direct contact with infested
freshwater. Travelers should be made aware of the risk of infection if
they come into contact with freshwater sources in schistosomiasisendemic areas. For people living in rural areas where schistosomiasis
is endemic, it may be very difficult, if not impossible, to avoid water
contact—for example, during occupational activities such as fishing
and working in rice fields. Schistosomiasis is a poverty-related disease,
and access to safe water and good sanitary facilities may rarely be available. Because S. japonicum is a zoonotic parasite, preventive measures
should target not only the human population but also animals such as
water buffalo, which act as reservoirs for infection.
Praziquantel treatment of infected people, often during mass
drug-administration programs, is a cornerstone of the management
and control of schistosomiasis. Regular treatment will reduce the
level of schistosomiasis morbidity in affected populations. However,
treatment should be combined with other relevant strategies, such as
control of the intermediate host snails, improved water-quality and
sanitation facilities, and health education. Schistosomiasis control
measures should be integrated into local health programs.
There have been intensive efforts to develop vaccines, but none is
yet available. Two vaccine candidates are in clinical phase 1 trials and
one is in phase 2 trials. Only one candidate, S. haematobium 28GST,
has been tested in a clinical phase 3 trial in populations living in an
endemic area. The vaccine candidate was immunogenic and well tolerated by infected children, but a sufficient efficacy was not reached.
FOOD-BORNE TREMATODE INFECTIONS
Food-borne trematode infections are a group of zoonotic diseases
caused by hepatic, intestinal, and pulmonary parasitic flukes. These
infections are contracted by ingestion of infective parasites in undercooked aquatic food or water plants. In 2015, an estimated 71 million
people were infected with food-borne trematodes, and infections cause
2 million life-years lost to disability and death worldwide every year.
■ LIVER FLUKES
The most important liver flukes causing human infections are the related
species Opisthorchis viverrini and Opisthorchis felineus, which cause opisthorchiasis; Clonorchis sinensis, which causes clonorchiasis; and Fasciola
hepatica and Fasciola gigantica, which cause fascioliasis (Table 234-1).
Opisthorchiasis and Clonorchiasis O. viverrini is found mainly
in northeastern Thailand, Laos, and Cambodia; O. felineus mainly in
Europe and Asia, including the former Soviet Union; and C. sinensis
in Asia, including Korea, China, Taiwan, Vietnam, Japan, and Asian
regions of Russia. Parasite eggs excreted from infected humans or
animals are ingested by a host snail (the first intermediate host), where
they undergo several developmental stages. Cercariae are then released
from the snail and penetrate freshwater fish (the second intermediate
host), encysting as metacercariae in the muscles or under the scales.
Humans become infected by eating raw or undercooked fish from
endemic countries. After ingestion, the metacercariae excyst in gastric
juices and migrate via the duodenum, the ampulla of Vater, and the
extrahepatic biliary system to the intrahepatic bile ducts.
TABLE 234–2 Treatment of Schistosomiasis and Food-Borne
Trematode Infections
INFECTION DRUG OF CHOICE ADULT DOSEa
Schistosoma mansoni, S.
haematobium, S. intercalatum,
S. guineensis
Praziquantelb 40 mg/kg PO in 2 divided
doses for 1 day
S. japonicum, S. mekongi Praziquantel 60 mg/kg PO in 3 divided
doses for 1 day
Clonorchis sinensis,
Opisthorchis viverrini,
Opisthorchis felineus
Praziquantel 25 mg/kg PO tid for
2 consecutive days
Fasciola hepatica, Fasciola
gigantica
Triclabendazolec 2 doses of 10 mg/kg PO
given 12 h apart
Fasciolopsis buski Praziquantel 75 mg/kg PO in 3 divided
doses for 1 day
Echinostoma spp., Heterophyes
heterophyes, several other
species
Praziquantel 25 mg/kg PO tid
Paragonimus westermani,
Paragonimus kellicotti
Praziquantel
Triclabendazolec
25 mg/kg PO tid for
2 consecutive days
10 mg/kg PO once (or
twice, 12–24 h apart)
a
The pediatric dose is the same as the adult dose in all instances. b
The safety of
praziquantel in children <4 years old has not been established, although many
children in this age group have been treated with praziquantel during mass drugadministration programs. c
In February 2019, the U.S. Food and Drug Administration
(FDA) approved triclabendazole for treatment of fascioliasis in patients at least 6
years of age.
1789CHAPTER 234 Schistosomiasis and Other Trematode Infections
The clinical manifestations of infection with Opisthorchis species
and C. sinensis are similar. Pathologic changes are typically seen in
the bile ducts, liver, and gallbladder (Table 234-3). Tissue damage and
intense inflammation are caused by mechanical and chemical irritation and immune responses to worms or worm products, and chronic
inflammation may result in the development of cholangiocarcinoma.
Both O. viverrini and C. sinensis are classified by the IARC as definitely
carcinogenic (class 1). Acute and light infections are mostly asymptomatic, but hepatitis-like signs and symptoms, with high fever and chills,
have been reported, especially in O. felineus infections. In general,
only heavily infected people have symptoms and severe complications
(Table 234-3).
The diagnosis of these infections is based on microscopic identification of parasite eggs in stool specimens. The eggs of Opisthorchis are
indistinguishable from those of Clonorchis.
Fascioliasis Fascioliasis occurs in many areas of the world and usually is caused by Fasciola hepatica, a common liver fluke of sheep and
cattle. F. hepatica is found in more than 50 countries on all continents
except Antarctica; F. gigantica is less widespread. The areas with the
highest known rates of human Fasciola infection are in the Andean
highlands of Bolivia and Peru. In other areas where fascioliasis is
found, human cases are sporadic.
Unlike the other liver flukes, Fasciola species have no second
intermediate host, as their infectious metacercariae adhere directly to
aquatic plants. Humans usually acquire infection by ingesting aquatic
plants, such as watercress, that contain viable metacercariae or by
drinking water with free metacercariae.
After metacercariae have excysted in the duodenum, Fasciola species migrate through the intestinal wall into the body cavity, penetrate
the liver capsule, and move through the liver into the bile ducts. This
migration route is different from that of other liver flukes and gives rise
to symptoms during the acute migratory phase; the parasites may cause
tissue destruction, focal bleeding, and inflammation. Some migrating
flukes may deviate from their usual route to cause ectopic infections.
In the established latent stage of infection, the parasites may cause bile
duct inflammation, resulting in thickening and expansion of the ducts,
fibrosis, and ultimately biliary obstruction (Table 234-3). Although
some infected people are asymptomatic in the latent phase, others may
experience repeated relapses of acute manifestations.
The most widely used diagnostic approach is direct detection of
Fasciola eggs by microscopic examination of stool or of duodenal or
biliary aspirates. Eggs generally cannot be detected until 3–4 months
after exposure, whereas antibodies to the parasite may become detectable 2–4 weeks after exposure. More than one stool specimen may be
needed for diagnosis, especially in light infections.
■ INTESTINAL FLUKES
More than 70 species of intestinal flukes can cause human infection.
These parasites are found in different geographic areas, with a relatively
high prevalence in Southeast Asia. Humans are infected by ingestion of
infective metacercariae attached to aquatic plants (Fasciolopsis buski) or
encysted in freshwater fish. Flukes mature in the human intestines, and
eggs are passed with feces. Mechanical irritation of the intestinal wall
and inflammation may lead to nonspecific gastrointestinal symptoms
such as diarrhea, constipation, and abdominal pain. Most individuals
infected with intestinal flukes are asymptomatic, but heavy infections
can be severe, with intestinal mucosal ulcerations and malabsorption
(Table 234-3). The diagnosis is established by detection of eggs in stool
samples. However, eggs from various intestinal trematodes are often
morphologically similar, and it is very difficult to distinguish among
species. A cautionary note: Fasciola eggs can be difficult to distinguish
on the basis of morphologic criteria from the eggs of the intestinal
fluke F. buski. The distinction has implications for therapy: infection
with F. buski is treated with praziquantel, which is not effective against
fascioliasis (Table 234-2).
■ LUNG FLUKES
Paragonimiasis is a parasitic lung infection caused by lung flukes of
the genus Paragonimus. It is a food-borne parasitic zoonosis, with
most cases reported from Asia and attributable to consumption of
raw or undercooked freshwater crustaceans. Paragonimus westermani
and related species (e.g., Paragonimus africanus) are endemic in
West Africa, Central and South America, and Asia. The United States
has one indigenous species of lung fluke, Paragonimus kellicotti.
Paragonimus species require two intermediate hosts: first, a freshwater snail; and second, a freshwater crustacean, such as a freshwater crab.
Humans are infected by consuming raw or undercooked infected crustaceans containing Paragonimus metacercariae. Paragonimus infects
other carnivores such as cats, dogs, foxes, rodents, and pigs in addition to humans. After ingestion, metacercariae quickly penetrate the
duodenum and traverse the peritoneal cavity, diaphragm, and parietal
pleura to mature into hermaphroditic worm pairs in the pleural spaces
or lungs within 6–10 weeks. Adults cross-fertilize in cystic cavities
in the pleural spaces or lungs within another 4–16 weeks and release
unembryonated eggs into bronchioles. The eggs are then coughed up in
TABLE 234–3 Clinical Features of Food-Borne Trematode Infections
SYMPTOMS OR SIGNS
INFECTION EARLY OR ACUTE STAGE ESTABLISHED OR CHRONIC STAGE COMPLICATIONS
Liver Flukes
Clonorchis sinensis,
Opisthorchis viverrini,
Opisthorchis felineus
Often asymptomatic; sometimes
hepatitis-like symptoms and high fever
(especially with O. felineus)
Biliary colic, cholestatic jaundice, recurrent
cholangitis and cholelithiasis; hepatomegaly,
gallbladder enlargement, periductal fibrosis. Light
infections are often asymptomatic and remain so
for years.
Pancreatitis, cholangiocarcinomaa
Fasciola hepatica,
Fasciola gigantica
Acute onset (1–4 weeks after infection)
with high fever, weight loss, sometimes
urticaria and liver tenderness
Biliary colic, cholestatic jaundice, recurrent
cholangitis and cholelithiasis; thickening,
enlargement, and fibrosis of biliary ducts;
sometimes repeated relapses of acute symptoms
Pancreatitis. In rare cases: ectopic
infections in the central nervous system,
orbital area, gastrointestinal tract, lungs,
and other organs. Rarely, fascioliasis can
be fatal.
Intestinal Flukes
Fasciolopsis buski,
Echinostoma spp.,
Heterophyes heterophyes,
several other species
Often asymptomatic; sometimes
nonspecific gastrointestinal symptoms
Heavy infection may lead to ulceration of
intestinal mucosa and malabsorption. Mild
infections are often asymptomatic.
Malnutrition, anemia; rarely, ectopic
infection in the central nervous system
Lung Flukes
Paragonimus westermani,
Paragonimus kellicotti
Often asymptomatic; sometimes
insidious onset with anorexia and
weight loss
Bronchitis-, asthma-, and tuberculosis-like
symptoms and signs such as chronic cough,
dyspnea, bloody (“rusty”) sputum
Pulmonary cyst formation; ectopic infection
in the central nervous system, eyes, skin,
heart, abdominal and reproductive organs
a
Carcinogenesis has not yet been established for O. felineus.
1790 PART 5 Infectious Diseases
bloody (“rusty”) sputum and either discharged in sputum or swallowed
and later excreted in feces. Unembryonated eggs are passed from the
mammalian host into freshwater ecosystems, where they infect intermediate host snails.
The symptoms and signs of paragonimiasis are fever, cough, hemoptysis, and peripheral eosinophilia. Some patients with paragonimiasis
and low parasite burdens may remain relatively asymptomatic for
prolonged periods or may have recurrent attacks of cough, sputum
production, fever, and night sweats that mimic tuberculosis. Infective
metacercariae may migrate to extrapulmonary sites such as the brain
(cerebral paragonimiasis).
Pulmonary paragonimiasis is diagnosed by detection of parasite ova
in sputum and/or feces. Serology can be helpful in egg-negative cases
and in cerebral paragonimiasis. Anamnestic information about the
consumption of raw or undercooked freshwater crabs by immigrants,
expatriates, and returning travelers—and, in the United States, the
consumption of raw or undercooked crayfish from freshwater river
systems where P. kellicotti is endemic—is important in patients presenting with fever, cough, hemoptysis, pleural effusions, and peripheral
eosinophilia.
TREATMENT
Food-Borne Trematode Infections
Praziquantel and triclabendazole are the two drugs of choice;
Table 234-2 summarizes the dosages recommended for the various
trematode infections. All confirmed cases of human paragonimiasis
should be treated with praziquantel (Table 234-2) to avoid the complications of extrapulmonary disease. Surgical management may be
needed for pulmonary or cerebral lesions.
■ CONTROL AND PREVENTION
Drugs are currently the main method of controlling the morbidity
associated with food-borne trematode infections, but integrated programs (including improved sanitation; food inspections; and information, education, and communication campaigns) are important
for sustainable disease control. Collaboration with other sectors (e.g.,
agricultural, environmental, and educational) is necessary to tackle
highly complex situations in which human behavior, biological factors,
and agricultural practices all play a role.
■ FURTHER READING
Andrade G et al: Decline in infection-related morbidities following
drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis. PLoS Negl Trop Dis
11:e0005372, 2017.
Cucchetto G et al: High-dose or multi-day praziquantel for imported
schistosomiasis? A systematic review. J Travel Med 26:taz050,
2019.
Fried B, Abruzzi A: Food-borne trematode infections of humans in
the United States of America. Parasitol Res 106:1263, 2010.
Fürst T et al: Global burden of human food-borne trematodiasis:
A systematic review and meta-analysis. Lancet Infect Dis 12:210,
2012.
Jordan P et al (eds): Human Schistosomiasis. CAB International,
Wallingford, 1993.
Keiser J, Utzinger J: Food-borne trematodiases. Clin Microbiol Rev
22:466, 2009.
Mcmanus DP et al: Schistosomiasis. Nat Rev Dis Primers 4:13, 2018.
Ross AG et al: Katayama syndrome. Lancet Infect Dis 7:218, 2007.
Sripa B et al: Update on pathogenesis of opisthorchiasis and cholangiocarcinoma. Adv Parasitol 102:97, 2018.
World Health Organization: Female Genital Schistosomiasis:
A Pocket Atlas for Clinical Health-Care Professionals. Geneva, World
Health Organization, 2015. Available at http://brightresearch.org/
wp-content/uploads/2016/05/FGS-pocket-atlas_eng.pdf. WHO/HTM/
NTD/2015.4, 2015. Accessed March 16, 2020.
Cestodes, or tapeworms, are segmented flat worms. The adult worms
reside in the gastrointestinal tract, but the larvae can be found in
almost any organ. Human tapeworm infections can be divided into two
major clinical groups. In one group, humans are the definitive hosts,
with the adult tapeworms living in the gastrointestinal tract (Taenia
saginata, Diphyllobothrium, and Dipylidium caninum). In the other,
humans are intermediate hosts, with larval-stage parasites present in
the tissues; diseases in this category include echinococcosis, sparganosis, and coenurosis. Humans may be the definitive and/or intermediate
hosts for Taenia solium; both stages of Hymenolepis nana are found
simultaneously in the human intestines.
The ribbon-shaped tapeworm attaches to the intestinal mucosa
by means of sucking cups or hooks located on the scolex. Behind
the scolex is a short, narrow neck from which proglottids (segments)
form. As proglottids mature, they are displaced further back from the
neck by the formation of new, less mature segments. The progressively
elongating chain of attached proglottids, called the strobila, constitutes
the bulk of the tapeworm. The length varies among species. In some,
the tapeworm may consist of more than 1000 proglottids and may be
several meters long. The mature proglottids are hermaphroditic and
produce eggs, which are subsequently released. Because eggs of the different Taenia species are morphologically identical, only morphologic
differences in the scolices or proglottids enable species-level diagnosis.
Most human tapeworms require at least one intermediate host for
complete larval development. After ingestion of the eggs or proglottids by an intermediate host, the invasive larvae (oncospheres) are
activated, escape the egg, and penetrate the intestinal mucosa. The
oncosphere migrates to tissues and develops into an encysted form
known as a cysticercus (single scolex), a coenurus (multiple scolices), or
a hydatid (cyst with daughter cysts, each containing several protoscolices). The definitive host’s ingestion of tissues containing a cyst enables
a scolex to develop into a tapeworm.
■ TAENIASIS SAGINATA AND TAENIASIS ASIATICA
The beef tapeworm T. saginata occurs in all countries where raw or
undercooked beef is eaten. It is most prevalent in sub-Saharan African and Middle Eastern countries. Taenia asiatica is closely related to
T. saginata and is found in Asia, with pigs as intermediate hosts. The
clinical manifestations and morphology of these two species are very
similar and are therefore discussed together.
Etiology and Pathogenesis Humans are the only definitive host
for the adult stage of T. saginata and T. asiatica. The tapeworms, which
can reach 8 m in length with 1000–2000 proglottids, inhabit the upper
jejunum. The scolex of T. saginata has four prominent suckers, whereas
T. asiatica has an unarmed rostellum. Each gravid segment has 15–30
uterine branches (in contrast to 8–12 for T. solium). The eggs are indistinguishable from those of T. solium; they measure 30–40 μm, contain
the oncosphere, and have a thick brown striated shell. Eggs deposited
on vegetation can live for months or years until they are ingested by
cattle or other herbivores (T. saginata) or pigs (T. asiatica). The embryo
released after ingestion invades the intestinal wall and is carried to striated muscle or viscera, where it transforms into the cysticercus. When
ingested in raw or undercooked meat, the cysticercus evaginates and
forms a tapeworm in the human intestines. Over ~2 months, the adult
worm matures and begins to produce eggs.
Clinical Manifestations Patients become aware of the infection
most commonly by noting passage of proglottids in their feces. The
proglottids of T. saginata are motile, and patients may experience
perianal discomfort when proglottids are discharged. Mild abdominal
pain or discomfort, nausea, change in appetite, weakness, and weight
loss can occur.
235 Cestode Infections
A. Clinton White, Jr., Peter F. Weller
1791CHAPTER 235 Cestode Infections
Diagnosis The diagnosis is made by the detection of eggs or proglottids in the stool. Eggs may also be present in the perianal area; thus,
if proglottids or eggs are not found in the stool, the perianal region
should be examined with use of a cellophane-tape swab (as in pinworm
infection; Chap. 232). Distinguishing T. saginata or T. asiatica from
T. solium requires examination of mature proglottids or the scolex.
Available serologic tests are not helpful diagnostically. Eosinophilia and
elevated levels of serum IgE are usually absent.
TREATMENT
Taeniasis Saginata and Taeniasis Asiatica
A single dose of praziquantel (10 mg/kg) is highly effective. Niclosamide (adult dose, 2 g; 1 g for children weighing 11−34 kg) is also
effective but is less available.
Prevention The major method of preventing infection is the adequate cooking of beef or pork viscera; exposure to temperatures as low
as 56°C for 5 min will destroy cysticerci. Refrigeration or salting for
long periods or freezing at –10°C for 9 days also kills cysticerci in beef.
General preventive measures include inspection of beef and proper
disposal of human feces.
■ TAENIASIS SOLIUM AND CYSTICERCOSIS
The pork tapeworm T. solium can cause two distinct forms of infection in humans: adult tapeworms in the intestine or larval forms in
the tissues (cysticercosis). Humans are the only definitive hosts for
T. solium; pigs are the usual intermediate hosts, although other animals
may harbor the larval forms.
T. solium is found worldwide in areas where pigs are raised and have
access to human feces. However, it is most prevalent in Latin America,
sub-Saharan Africa, China, India, and Southeast Asia. Cysticercosis
occurs in industrialized nations largely as a result of the immigration
of infected persons from endemic areas.
Etiology and Pathogenesis The adult tapeworm generally resides
in the upper jejunum. The scolex attaches by both sucking disks and
two rows of hooklets. The adult worm usually lives for a few years. The
mature tapeworm, usually ~3 m in length, may have as many as 1000
proglottids, each of which produces up to 50,000 eggs. Proglottids are
released and excreted into the feces, and the eggs in these proglottids are
infective for both humans and animals. After ingestion of eggs by the pig
intermediate host, the invasive larvae are activated, escape the egg, penetrate the intestinal wall, and are carried via the bloodstream to many
tissues; they are most frequently identified in striated muscle of the
neck, tongue, and trunk. Within 60–90 days, the encysted larval stage
develops. These cysticerci can survive for months to years. By ingesting
undercooked pork containing cysticerci, humans acquire infections that
lead to intestinal tapeworms. Infections that cause human cysticercosis
follow the ingestion of T. solium eggs. Transmission is usually associated
with close contact with a tapeworm carrier. The eggs are sticky and may
be found under the fingernails of tapeworm carriers. Autoinfection may
occur if an individual with an egg-producing tapeworm ingests eggs
derived from his or her own feces.
Clinical Manifestations Intestinal infections with T. solium may
be asymptomatic. Fecal passage of proglottids may be noted by
patients. Other symptoms are infrequent.
In cysticercosis, the clinical manifestations are variable. Cysticerci
can be found anywhere in the body but are most commonly detected
in the brain, cerebrospinal fluid (CSF), skeletal muscle, subcutaneous
tissue, or eye. The clinical presentation of cysticercosis depends on the
number and location of cysticerci as well as on the extent of associated
inflammatory responses or scarring. Neurologic manifestations are the
most common (Fig. 235-1). Seizures are associated with inflammation
surrounding cysticerci in the brain parenchyma. These seizures may
be generalized, focal, or Jacksonian. Hydrocephalus results from CSF
flow obstruction by cysticerci and accompanying inflammation or by
CSF outflow obstruction from arachnoiditis. Symptoms of increased
intracranial pressure, including headache, nausea, vomiting, changes
in vision, dizziness, ataxia, or confusion, are often evident. Patients
with hydrocephalus may develop papilledema or display altered mental
status. When cysticerci develop at the base of the brain or in the subarachnoid space, they may cause chronic meningitis or arachnoiditis,
communicating hydrocephalus, hemorrhages, or strokes.
Diagnosis The diagnosis of intestinal T. solium infection is made
by the detection of eggs or proglottids, as described for T. saginata.
More sensitive methods, including antigen-capture enzyme-linked
immunosorbent assay (ELISA), polymerase chain reaction (PCR), and
serology for tapeworm stage-specific antigens, are currently available
only as research techniques. In cysticercosis, diagnosis can be difficult.
A panel of international experts recently proposed revised diagnostic
criteria (Table 235-1). Diagnostic certainty is possible only with definite demonstration of the parasite (absolute criteria). This task can be
accomplished by histologic observation of the parasite in excised tissue,
by funduscopic visualization of the parasite in the subretinal space of
the eye, or by neuroimaging studies with definite evidence of a cystic
lesion containing a characteristic scolex (Fig. 235-1). With improving
resolution of neuroimaging studies, the scolex can now be identified
in a large proportion of cases. In other instances, a clinical diagnosis is
based on a combination of clinical presentation, radiographic studies,
exposure history, and serodiagnosis.
Neuroimaging findings constitute the primary major diagnostic criteria (Fig. 235-1). Major findings include cystic lesions with or without
enhancement (e.g., ring enhancement), one or more nodular calcifications (which may also have associated enhancement), focal enhancing
lesions, or multilobulated cystic lesions in the subarachnoid space.
Cysticerci in the brain parenchyma are usually 5–20 mm in diameter
and rounded. Cystic lesions in the subarachnoid space or fissures may
enlarge up to 6 cm in diameter and may be lobulated. For cysticerci
within the subarachnoid space or ventricles, the walls may be very
thin and the cyst fluid is often isodense with CSF. Thus, obstructive
hydrocephalus or enhancement of the basilar meninges may be the
only finding on CT in extraparenchymal neurocysticercosis. However,
since these findings are less specific, they are considered only minor
criteria. Cysticerci in the ventricles or subarachnoid space are more
readily identified by MRI, especially with three-dimensional views
(e.g., fast imaging employing steady-state acquisition [FIESTA] or
three-dimensional constructive interference in steady state [3D CISS]).
CT is more sensitive than MRI in identifying calcified lesions, whereas
MRI is better for identifying cystic lesions, scolices, and enhancement.
Spontaneous resolution, resolution after therapy with albendazole, or
mobile cystic lesions within the ventricles are findings that can support
the diagnosis of neurocysticercosis.
Prior exposure significantly modifies the interpretation of neuroimaging studies. Detection of specific antibodies to or antigens of
T. solium are major exposure criteria. Antibody tests using unfractionated antigens (e.g., ELISAs using crude parasite antigen) have high
rates of false-positive and false-negative results and should be avoided.
An immunoblot assay using lentil lectin–purified glycoproteins is
>99% specific and highly sensitive. However, patients with single
intracranial lesions or with calcifications may be seronegative. With
this assay, serum samples provide greater diagnostic sensitivity than
CSF. All of the diagnostic antigens have been cloned, and assays using
recombinant antigens are being developed. Antigen detection assays
using monoclonal antibodies to detect parasite antigen in the blood or
CSF may also facilitate diagnosis and patient follow-up. These assays
are currently available commercially in Europe but not in the United
States. More recently, real-time PCR has been employed for diagnosis
and follow-up of extraparenchymal disease.
Other major clinical/exposure criteria for neurocysticercosis include
the presence of cysticerci outside the central nervous system (CNS)
(e.g., typical cigar-shaped calcifications in muscle) or exposure to a
tapeworm carrier or a household member infected with T. solium.
Minor clinical/exposure criteria include residence in an endemic area
or clinical symptoms suggestive of neurocysticercosis (e.g., seizures or
obstructive hydrocephalus).
No comments:
Post a Comment
اكتب تعليق حول الموضوع